# 5WPR Publishes the Cannabis Communications Gap Report, Documenting Why a $38.5 Billion Industry Operates with Weak Communications > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-communications-gap-report-industry-challenges/ > **Published:** 2026-04-22T13:05:55-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:36:11-04:00 > **Clinical Summary:** Explore the cannabis communications gap report revealing challenges in medical cannabis patient education and clinical communication in a $38.5 billion industry. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Patient EducationIndustry Analysis[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)Clinical CommunicationHealthcare Access Why This Matters Poor communications infrastructure in the [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) directly impacts patient care by limiting access to reliable clinical information and perpetuating stigma that affects patient-provider discussions. This communications gap contributes to the persistent disconnect between cannabis medicine’s clinical potential and public understanding. Clinical Summary A public relations firm has published a report analyzing the communications challenges facing the $38.5 billion [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/), identifying structural weaknesses in how cannabis companies and stakeholders communicate with the public. The report appears to document systemic communications deficiencies that may contribute to ongoing misconceptions about [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and regulatory challenges. Without access to the full report methodology and findings, the specific communications barriers and their quantified impacts remain unclear. Dr. Caplan’s Take “This communications vacuum creates real clinical problems — patients often arrive with either unrealistic expectations or unnecessary fears, both driven by poor information quality. Until the industry invests in evidence-based communications, clinicians will continue doing damage control instead of focusing on optimal care.” Clinical Perspective 🧠 Clinicians should be aware that patients’ cannabis knowledge often comes from unreliable sources due to industry-wide communications failures. This reinforces the importance of evidence-based patient education and taking time to address misconceptions during consultations. The communications gap also underscores why [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) programs need robust clinical oversight and professional medical involvement. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%205WPR%20Publishes%20the%20Cannabis%20Communications%20Gap%20Report%2C%20Documenting%20Why%20a%20%2438.5%20....%20%40drcaplan&url=https%3A//www.prnewswire.com/news-releases/5wpr-publishes-the-cannabis-communications-gap-report-documenting-why-a-38-5-billion-industry-operates-with-the-weakest-communications-infrastructure-in-american-business-302746713.html)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.prnewswire.com/news-releases/5wpr-publishes-the-cannabis-communications-gap-report-documenting-why-a-38-5-billion-industry-operates-with-the-weakest-communications-infrastructure-in-american-business-302746713.html)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%205WPR%20Publishes%20the%20Cannabis%20Communications%20Gap%20Report%2C%20Documenting%20Why%20a%20%2438.5%20....%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.prnewswire.com/news-releases/5wpr-publishes-the-cannabis-communications-gap-report-documenting-why-a-38-5-billion-industry-operates-with-the-weakest-communications-infrastructure-in-american-business-302746713.html)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.prnewswire.com/news-releases/5wpr-publishes-the-cannabis-communications-gap-report-documenting-why-a-38-5-billion-industry-operates-with-the-weakest-communications-infrastructure-in-american-business-302746713.html](https://www.prnewswire.com/news-releases/5wpr-publishes-the-cannabis-communications-gap-report-documenting-why-a-38-5-billion-industry-operates-with-the-weakest-communications-infrastructure-in-american-business-302746713.html) Table of Contents - [FAQ](#FAQ)[What is the CED Clinical Relevance rating system?](#What_is_the_CED_Clinical_Relevance_rating_system) - [What type of content does this cannabis news article cover?](#What_type_of_content_does_this_cannabis_news_article_cover) - [Who is the target audience for this CED Clinic content?](#Who_is_the_target_audience_for_this_CED_Clinic_content) - [What does “Notable Clinical Interest” mean in this context?](#What_does_8220Notable_Clinical_Interest8221_mean_in_this_context) - [How does this article fit into the broader cannabis news landscape?](#How_does_this_article_fit_into_the_broader_cannabis_news_landscape) - [Related](#Related) ## FAQ #### What is the CED Clinical Relevance rating system? The CED Clinical Relevance system appears to be a rating scale that categorizes medical cannabis news and developments. This article received a rating of #70, classified as “Notable Clinical Interest” for emerging findings or policy developments worth monitoring closely. #### What type of content does this cannabis news article cover? This article focuses on patient education, industry analysis, medical cannabis, and clinical communication topics. It’s designed to provide healthcare professionals and patients with relevant information about [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) developments. #### Who is the target audience for this CED Clinic content? The content appears to be aimed at healthcare professionals, clinicians, and patients interested in medical cannabis developments. The clinical relevance rating and professional formatting suggest it’s designed for medical practitioners who need to stay informed about cannabis medicine. #### What does “Notable Clinical Interest” mean in this context? Notable Clinical Interest indicates that the article contains emerging findings or policy developments in medical cannabis that are worth monitoring closely by healthcare professionals. It suggests the information may impact clinical practice or patient care in the future. #### How does this article fit into the broader cannabis news landscape? This article is part of CED Clinic’s cannabis news coverage, which appears to focus on clinically relevant developments rather than general cannabis industry news. The emphasis on patient education and clinical communication suggests a medical-focused approach to cannabis reporting. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) is more than a scientific pursuit—it's a pathway to better health, informed … Explore how [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) advances clinical knowledge and patient care beyond science alone. Read More [It was once deemed taboo, and still today medical marijuana comes with some stigma … – Facebook](https://cedclinic.com/healthcare-stigma-cannabis-barriers-medical-use/) Understand the ongoing stigma surrounding [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and its impact on patient-provider communication. [Learn More](https://cedclinic.com/healthcare-stigma-cannabis-barriers-medical-use/) [Boston's Cannabis Industry Hub](https://cedclinic.com/municipal-cannabis-business-development-boston/) Discover how Boston's cannabis industry hub is shaping communication and clinical practices. [Explore Now](https://cedclinic.com/municipal-cannabis-business-development-boston/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).